1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 4:Clinical and radiologic outcome analysis by presentation and SAH severity
Complication Rate Mortality Rate Glasgow Outcome Score Occlusion Subsequent Procedure 1 2 3 4 Total Subtotal Incomplete Presentation SAH 10/80 (12.5) 4/80 (5) 55/75 (73.3) 0 9/75 (12) 11/75 (14.7) 67/80 (83.8) 4/80 (5) 9/80 (11.2) 15/80 (18.75) Mass effect 1/17 (5.9) 1/17 (5.9) 15/16 (93.7) 0 0 1/16 (6.3) 13/17 (76.5) 2/17 (11.75) 2/17 (11.75) 4/17 (23.5) SAH severity I 3/46 (6.5) 1/46 (2.2) 35/44 (79.5) 0 4/44 (9.1) 5/44 (11.4) 40/46 (86.9) 1/46 (2.1) 5/46 (11) 7/46 (15.2) II 2/12 (16.7) 0 7/12 (58.3) 0 2/12 (16.7) 3/12 (25) 8/12 (66.7) 3/12 (25) 1/12 (8.3) 2/12 (16.7) III 3/5 (60) 0 3/5 (60) 0 1/5 (20) 1/5 (20) 4/5 (80) 0 1/5 (20) 1/5 (20) IV 1/11 (9.1) 0 8/11 (72.7) 0 1/11 (9.1) 2/11 (18.2) 10/11 (90.9) 0 1/11 (9.1) 2/11 (18.2) V 2/6 (33.3) 3/6 (50) 2/3 (66.7) 0 1/3 (33.3) 0 5/6 (83.3) 0 1/6 (16.7) 0
Note.—Numbers in parentheses are percentages.